Alembic Pharmaceuticals Limited (APLLTD.NS)
Company Info
| ISIN | INE901L01018 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | ₹184.44B |
|---|---|
| EPS | ₹30.03 |
| PE Ratio | 31.25 |
| Revenue (TTM) | ₹61.18B |
| Gross Profit (TTM) | ₹39.44B |
| EBITDA (TTM) | ₹8.62B |
| Year Range | ₹526.49 - ₹1,094.00 |
| Target Price | ₹862.25 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of ₹10,000 in Alembic Pharmaceuticals Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Alembic Pharmaceuticals Limited had a return of 26.15% year-to-date (YTD) and 79.05% in the last 12 months. Over the past 10 years, Alembic Pharmaceuticals Limited had an annualized return of 13.45%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 26.15% | 6.33% |
| 1 month | 0.06% | -2.81% |
| 6 months | 26.24% | 21.13% |
| 1 year | 79.05% | 24.56% |
| 5 years (annualized) | 12.58% | 11.55% |
| 10 years (annualized) | 13.45% | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 26.48% | 6.16% | -3.42% | |||||||||
| 2023 | 1.00% | -9.10% | 4.59% | 1.82% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Alembic Pharmaceuticals Limited(APLLTD.NS)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Alembic Pharmaceuticals Limited (APLLTD.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Alembic Pharmaceuticals Limited granted a 0.84% dividend yield in the last twelve months. The annual payout for that period amounted to ₹8.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹8.00 | ₹8.00 | ₹10.00 | ₹14.00 | ₹3.00 | ₹5.50 | ₹4.00 | ₹4.00 | ₹4.00 | ₹3.50 | ₹3.00 | ₹2.50 |
Dividend yield | 0.84% | 1.05% | 1.75% | 1.75% | 0.29% | 0.96% | 0.67% | 0.75% | 0.67% | 0.50% | 0.67% | 1.18% |
Monthly Dividends
The table displays the monthly dividend distributions for Alembic Pharmaceuticals Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | ₹0.00 | ₹0.00 | ₹0.00 | |||||||||
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹8.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹10.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2021 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹14.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2020 | ₹0.00 | ₹0.00 | ₹3.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹5.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2017 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2016 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2015 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2014 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹3.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2013 | ₹2.50 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Alembic Pharmaceuticals Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alembic Pharmaceuticals Limited was 57.14%, occurring on Mar 29, 2023. The portfolio has not yet recovered.
The current Alembic Pharmaceuticals Limited drawdown is 11.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -57.14% | Dec 18, 2020 | 566 | Mar 29, 2023 | — | — | — |
| -45.05% | Jul 17, 2015 | 712 | Jun 5, 2018 | 460 | Apr 24, 2020 | 1172 |
| -27.58% | Nov 9, 2011 | 37 | Jan 2, 2012 | 64 | Apr 2, 2012 | 101 |
| -23.65% | Apr 28, 2014 | 15 | May 19, 2014 | 34 | Jul 4, 2014 | 49 |
| -20.67% | Jul 30, 2013 | 15 | Aug 21, 2013 | 34 | Oct 10, 2013 | 49 |
Volatility
Volatility Chart
The current Alembic Pharmaceuticals Limited volatility is 6.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |